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Summary.-Mononuclear-cell suspensions of lymph nodes, spleen and blood from
24 patients with active Hodgkin's disease (HD) were studied for possible imbalance
of T and B lymphocytes, and T-lymphocyte subsets, using monospecific anti-T
antibodies and other reagents. A profile showing T-cell predominance was demon-
strated ln lymph nodes and blood, with total T-cells ranging from 50-70% of the
cell count. As defined by monoclonal antibodies, 70-85% of the latter comprised the
"inducer" subclass, the remainder being "suppressor" cells. There were no essential
differences between histologically involved and uninvolved lymph nodes from HD
patients, though total T-cell proportions were lower in "normal lymph node" con-
trols. The profiles of spleens electively removed, as part of pre-treatment staging
procedures, showed reduced total T-cell numbers, whether these were involved with
HD or not. These differences are accounted for principally by fewer T "inducer" cells
(24%, in spleen, v. 54% in involved lymph nodes and47% in "normal" control nodes).
Possible explanations for these findings are discussed. Our results demonstrate
similar profiles in histologically diseased and normal tissue, rather than any clear
imbalance of T-cell proportions which might explain the profound disturbances
of T-cell function frequently demonstrated in vivo and in vitro.
THE NATURAL HISTORY of Hodgkin's
disease (HD) is that of a chronic pro-
gressive illness which, untreated, is almost
invariably fatal. It is manifested clinically
and pathologically by features common to
both a true malignancy and a chronic
inflammatory process.
The association of HD with often
profound disturbances of cell-mediated
immunity, in vivo and in vitro, is well
recognized (Reed, 1902; Parker et al.,
1932; Steiner, 1934; Schier et al., 1956;
Aisenberg, 1966; Levy & Kaplan, 1974)
and has prompted considerable research
to determine whether this is intrinsic to
the pathogenesis of HD (Levy & Kaplan,
1974; Eltringham & Kaplan, 1973; Bob-
rove et al., 1975; Jackson & Parker, 1947;
Young et al., 1973), or a secondary
phenomenon related to stage of disease,
and reversible after successful therapy
(Jackson & Parker, 1947; Sokal & Pri-
mikirios, 1961; Sokal, 1973).
The recognition of 2 functionally
distinct majorT-cell subclasses, "inducer"/
"helper" and "suppressor"/"cytotoxic"
(Rowley et al., 1973; Dutton, 1975;
Webb & Jamieson, 1976; Moretta et al.,
1977; Evans et al., 1978) has led to the
recent development of monoclonal anti-
bodies against T-cell antigens (Kung
et al., 1979; Hoffman et al., 1980; Rein-
herz et al., 1979a, b, 1980) which has thus
provided a consistently reproducible
means ofrapidly and accurately quantify-
ing these cells. We report below on our
experiments using these reagents, in
single-cell suspensions of tissues obtainedM. S. DORREEN ET AL.
from HD patients, in order to identify
possible T-cell imbalances.
MATERIALS AND METHODS
Patients
Material from 24 patients with active,
untreated Hodgkin's disease forms the basis
of this report. This comprised lymphocyte
suspensions prepared from lymph nodes,
spleen and peripheral blood. Histological
classification was according to the Rye
nomenclature (Lukes & Butler, 1966). Clinical
and pathological staging was according to
the Ann Arbor method (Carbone et al.,
1971). Details of the pre-treatment patients
are given in Table I.
TABLE I.-Pre-treatment patient details
Males, 15; Females, 9; Total, 24
(mean age 30*5 yr)
Histological types
Lymphocyte predominance
Nodular sclerosis
Mixed cellularity
Lymphocyte depletion
Clinical/pathological
stages
6 IA 6
12 IIA 12
5 IIIA I
IIIB 1
1 IVB 4
An additional 3 patients were submitted
for elective laparotomy and splenectomy.
after successful completion of combination
chemotherapy, to exclude residual, active
intra-abdominal HD, and to act as a guide
for future management decisions. For com-
parison the spleens from these patients were
studied using the reagents detailed below.
Controls
A group of 15 normal blood donors (mean
age 31 years) provided controls for the
patient group. A "normal" lymphoid-tissue
control group (mean age 24-5 yr) was pro-
vided by 8 tonsils from patients undergoing
elective tonsillectomy, and histologically
reactive lymph nodes removed to exclude
possible relapse, in 2 patients treated several
years previously for HD.
In addition, 2 histologically normal spleens
obtained at diagnostic laparotomy were
studied; one was removed from a patient
with Wegener's granuloma and renal failure,
the other from a patient with suspected
intra-abdominal lymphoma. This diagnosis
was unequivocally refuted after histological
examination.
Tissue preparation
Lymph node.-Surgical biopsy specimens
were bisected for histological examination
and phenotyping. A single-cell suspension
of the latter portion was prepared by teasing
out in RPMI 1640. The cells were washed
twice in the same medium.
Tonsil.-Single-cell suspensions were pre-
pared as for lymph node.
Peripheral blood.-Lymphocytes were ob-
tained from 50-60 ml of blood separated
by centrifugation on a Ficoll-Triosil (Lym-
phoprepR) gradient. The cell layer at the
interface was harvested and washed twice in
RMPI 1640.
Spleen.-About 8 ml of tissue obtained
from spleens removed at staging laparotomy
were teased into single-cell suspensions.
Mononuclear cells were separated on Lym-
phoprepR and washed twice in PRMI 1640.
Reagents
Monoclonal antibodies reactive with T
lymphocytes included the OKT series (Ortho
Pharmaceuticals, Raritan, NJ, U.S.A.) and
the Leu series (Becton Dickinson Antibody
Center, Sunnyvale, CAL, U.S.A.). The T-
cell-subset specificity of these reagents has
been extensively documented (Kung et al.,
1979; Hoffman et al., 1980; Reinherz et al.,
1979a, b, 1980. Becton Dickinson, 1981)
(Table II).
TABLE II.-T-cell specificity of monoclonal
antibodies
OKTI/Leul Pan T cell (mature peripheral T
cells, some thymocytes and some
B cells)
OKT3 Mature, peripheral T cells
OKT4/Leu-3A T "inducer"/"helper" subset
OKT6 Cortical thymocyto
OKT8/Leu2A T "suppressor"/"cytotoxic" subset
B lymphocytes were defined as cells
bearing surface immunoglobulin, detected
by staining with polyvalent rabbit anti-
human Ig (G+M+A+D). Cells expressing
HLA-DR were also counted, using antibody
DA-2 (antimonomorphic-HLA-DR: Ia-like
antigen) (Brodsky et al., 1979). Light-chain
restriction of B cells was assessed using
fluorescein isothiocyanate (FITC)-labelled
rabbit anti-human antibody against K and
A light chains (Behringwerke).
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Other monoclonal reagents included mono-
morphic anti-HLA-A.B,C: W6/32 (Sera Lab,
Crawley Down, WA"est Sussex) expressed on
all leucocytes. w-hich provided a positive
control. Anti-platelet (Glycoprotein I) mono-
clonal antibody AN51 (McMichael et al.,
1981) provided a negative control.
Techniques
Viability oJ leucocyte suspensions.-This
was assessed by Trypan-blue dye exclusion.
Inmmunofluorescence.-Quantities of med-
ium (25 ,ul) containing 106 cells each were
incubated with 5 pA aliquots of monoclonal
antibody of known titre and antibody
concentration for 30 min at 4°C. After
wiashing twice in plhosphate-buffered saline
(PBS) the cell suspension uwas incubated
with 5 pA of FITC-labelled goat F(ab')2
-anti-mouse reagents for 30 min at 4°C.
For detection of cell surface Ig, 106 cells
were incubated directly Awith 5-15 t,l of
FITC-labelled (deaggregated) rabbit anti-
human heavy- or light-chain sera, for 30
min at 4°C. Cells w-ere wiashed tw-ice in
PBS and examined under UV, using a
Zeiss Plhotomicroscope TII equipped for
epifluorescence microscopy. Positive scores
were assessed as live cells showing bright
surface-membrane staining as clear rings,
caps or distinct speckling. To exclude back-
ground or non-specific fluorescence. cells
were also incubated wiith the FITC-labelled
second-layer antibody alone.
E rosettes.-These were performed using
washed sheep erythrocytes according to
methlods described by HabeshaN et al.
(1979). Positive E rosettes were scored as
mononuclear leucocytes wAith 3 or more
adherent sheep erythrocytes.
RESULTS
T lymphocytes
The T-cell proportions found in blood
and lymph nodes from patients and
controls are detailed in Table III and IV.
As defined by our results these tissues
show a T-cell predominance in which E-
rosetting (Er+) and OKT/Leu+ cells com-
prise 50-70% of all the mononuclear cells.
The majority (70-85%) of T lympho-
cytes, thus defined, are comprised of
cells expressing OKT4/Leu-3A (T "in-
ducer") antigens. In the main, the pro-
portions of cells expressing OKTI/Leu-1-
reactive antigen are lower than either
OKT3+ cells or the sum of (OKT4/
Leu-3A + OKT8/Leu-2A) but the differen-
ces are not significant. The percentages of
OKT3+ cells do, however, correlate well
with the sum (OKT4/Leu-3A +OKT8/
Leu-2A)+ cells, i.e. T ("inducer" + "sup-
pressor"). Differences in the relative
proportions of Er+ and pan-T antigen-
expressing cells vary but are not signifi-
cant. OKT6 antibody to thymic cortical
cells was negative in all tissues.
The differences between the percentages
of Er+ cells in involved lymph nodes and
"normal" controls are significant (Table
III). There is also an apparently significant
difference in the mean proportions of
OKT3+ cells between "normal" controls
and diseased nodes but not in total T-
cell proportions, defined by the sums of
(OKT4+ 8)+ and (Leu-3A + 2A)+ cells.
The surface-antigen profiles of mono-
nuclear cells from "disease control" lymph
nodes, do not differ significantly from
those in involved nodes. However, there
is a significant difference between mean
OKT8/Leu-2A (T "suppressor") values in
the "disease control" and "normal con-
trol" groups (18% and 11% respectively;
P=0O l).
No significant difference in results from
patient and control blood has been
demonstrated. The profiles are comparable
to those from lymph nodes.
The data from spleen-cell suspensions
however showed several differences (Table
V): the mean totals of mononuclear cells
expressing T-reactive antigens in spleens
from patients with untreated HD, were
lower than in either blood or lymph node
(P < 0-001). They are accounted for by
smaller relative proportions of OKT4/Leu-
3A+ cells.
The proportions of Er+ cells in pre-
treatment spleens equate with those in
lymph node and blood, and it follows that
the difference between the Er+ and
OKT/Lev+ population, in spleen, is also
significant (P<0.01). In addition the
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TABLE VI.-C(ell surface phenotypes in HD (%0 of total viable mononuclear-cell count)
Involved lymplh
nodes, by
hiistological type
Lymphocyte
predlominance
Nodtiular sclerosis
Mixed eelluilarity
Lymphocyte
(lepletiorn
No. ohs.
AMeari
s.e.
No. obs.
AMean
s.e.
No. obs.
Mlean
1 no(Ie
E
Rosettes l'an T
4 3
59 67
4
5 0
61 69
4 2
1 2
62 78
- 29)
OKT4/ OKT8/ T "h1elper" +
Leu-3A Leu-2A "suppressor
5
55
8
5
8
3
59
15
5
1 ()
6
21
.3 .5
3
8
x
65
8
76
7
:1
67
22
T "inducer": "suppressor" ratio defined
by OKT4/Leu-3A+: OKT8/Leu-2A+ cells
approximates to 1: 1, compared with
3-4:1, in blood and lymph node. Our
data reveal no phenotypic differences
between diseased and normal spleen.
Phenotype profiles of 3 spleens obtained
at laparotomy, after completion of chemo-
therapy, show decreased proportions of
T cells, as defined by Er+, OKTI, OKT3,
Leu-I and OKT4/Leu-3A+ cells.
Data from lymph nodes were analysed
according to the histological type of HD
(Table VI). In lymph nodes involved with
HD of lymphocyte-predominant type,
there is an apparently greater predomin-
ance of T "inducer" (OKT4/Leu-3A) to
T "suppressor" (OKT8/Leu-2A) lympho-
cytes (ratio 5: 1). One node involved with
HD of lymphocyte-depleted type shows
an overall reduction in T lymphocytes,
but with retention of T "helper" pre-
dominance. The numbers in each group
are too small to allow statistical com-
parison.
B lymphocytes
The estimated proportions of cells
defined either as surface-immunoglobulin-
bearing cells (SIg+) or HLA-DR (Ia+)
antigen-expressing cells, ranged from 12
to nearly 30o. Although there were some
differences in the numbers counted by
the two methods, these were not signifi-
cant. When assessed by light-chain anti-
sera, the B cells show a polyclonal profile.
Controls
All cells were strongly positive with
W6/32 antibody. No positive reactions
were seen with AN51, except with occa-
sional platelet fragments which appeared
as tiny, brilliantly fluorescing particles.
Background fluorescence was almost
always absent, apart from occasional faint,
diffuse intracytoplasmic fluorescence.
I)JSCUSSION
HD is characterized by the presence,
in affected tissue, of high levels of
"reactive" T lymphocytes. This could
indicate either a marked antigenic stimu-
lation by the neoplastic cell component
of the lesion, or a persistent non-specific
immune reaction. The frequently observed
rise in serum immunoglobulins and cir-
culating immune complexes (Madalinski
et al., 1970; Wagener et al., 1976; Amlot
et al., 1978; Brown et al., 1978) lends
support to theories of general over-
reactivity to chronic antigenic stimulation.
On the other hand, a T inducer: suppressor
imbalance in which the population of T
cells consisted entirely or largely of
inducer/helper cells, might lead to un-
balanced and persistent inappropriate
stimulation of B lymphocytes. In view of
the abnormal cellular immunity so fre-
quently observed, such lymphocytes might
well be defective, either in stimulating
or responding to antigenic challenge.
Whilst our data demonstrate a T-cell-
Ia
15
Smig
3
21
2 4
16 23
5
2
20 12
44
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predominant (Er+, OKTI+, OKT3+,
LEU-I+) cell population in diseased lymph
nodes and peripheral blood from the
patient population, the results are
essentially identical to those obtained with
the respective control tissues: uninvolved
lymph nodes from the patients and normal
donor blood.
Our results would appear to be at
variance with an earlier study (Romag-
nani et al., 1978) which showed an im-
balance of subsets of peripheral-blood
T-cells subsets in HD patients. Such cells
identified as Er+ cells expressing receptors
for either IgM(TIi) or IgG (Ty), have been
described by others (Moretta et al., 1977)
as subserving "helper"/"inducer" and
"suppressor"/"cytotoxic" functions re-
spectively. Romagnani was able to demon-
strate a decrease in Tu and an increase in
Ty subsets though Tp. lymphocytes re-
mained overall predominant. Gupta & Tan
(1980) demonstrated a small but non-
significant increase in Ty lymphocytes in
the blood of children with untreated HD.
These reports would thus suggest a
relative increase in the "suppressor"/
"cytotoxic" T-cell population in the blood
of HD patients. However, the methods
for assaying these subpopulations involve
reactions with quite different antigenic
determinants from those recognized by
the monoclonal antibodies, and it cannot
be assumed that identical subsets are
identified by the two methods.
Neither tonsils nor reactive lymph
nodes from patients "cured" of HD
might be regarded as appropriate control
material for normal lymph nodes, and
this reflects the difficulty in obtaining
non-diseased lymph nodes, particularly
from an age-matched group. Nonetheless,
our data do show similar phenotype
profiles, particularly in respect of the
T "helper":"suppressor" ratios, though
the overall degree of T-cell predominance
is marginally less than that in lymph-
node material from the patient population.
The findings accord with previous reports
of cell suspensions and frozen sections of
normal tissues (Reinherz & Schlossman,
1980; Janossy et atl., 1980; Poppema
et al., 1981).
Because of the limited selection of
histological types available for study, no
conclusions can be drawn about possible
T-cell differences in the 4 majorhistological
types, though there is a suggestion of a
higher proportion of T "inducer" lympho-
cytes in nodes involved with lympho-
cyte-predominant HlD than in other
subclasses. One lymph node from a
patient aged 14, with mixed-cellularity
HD, showed a T-helper population > 9000
of all cells, a marked predominance of
this T subset. Since most of our patients
presented with limited disease, it has
not been possible to relate our findings
to stage, or subsequent clinical progress.
Splenic T-cell populations may differ
from those of lymph node or peripheral
blood. A substantial proportion of Er+
cells fails to express either pan-T antigens
(OKTI, OKT3, Leu-1]) or "helper"/
"inducer" antigens (OKT4, Leu-3A). This
would imply the presence of an additional
subset ofT-cells, being either an immature
population at an intermediate stage of
differentiation, or a subset evolved in
response to, or intrinsic to the disease
process. Alternatively, it is conceivable
that such a population could be resident
in normal adult spleen. Gupta & Tan
(1 980) have demonstrated increased pro-
portions of T-cells bearing IgM receptors
in the spleens of their patients, who were,
however, all children, mainly with ad-
vanced disease or splenic involvement.
The theory of 'ecotaxopathy" pro-
posed by De Sousa et al. (1976) implies a
failure in HD of normal T-cell migration
and recirculation (ecotaxis) with a pref-
erential accumulation of these cells
within the spleen. De Sousa's study of
peripheral blood and spleen from 5
patients suggests that this abnormality
is intrinsic to HD, and independent of
stage or splenic involvement. Hunter
et aW. (1977) also demonstrated an overall
increase of Er+ cells in the spleens of
patients, but most had advanced disease
and heavy splenic infiltration, the highest
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Er values being obtained from the in-
volved spleens. In contrast, Payne et al.
(1976) found the highest Er levels in
uninvolved spleens, those in diseased
spleens being within normal limits. Kaur
et al. (1974) found normal levels of Er+
cells in the spleens of HD patients,
though responsiveness to PHA was in-
creased.
We have not demonstrated an overall
increase in Er+ cells in the spleens of our
patients although as discussed above
these may well be distinct from those in
peripheral nodes and blood. Only 1
patient, a 16-year-old female with nodular
sclerosing HD, had heavy splenic in-
volvement. Intriguingly, in this case the
proportion of Er+ cells was 78%, whilst
37% of the cells reacted with OKT1.
We conclude that our results, obtained
from single-cell suspensions of lymph
node, tonsil and peripheral blood, show
phenotypic similarities in these tissues
rather than any clear abnormalities.
Compared with involved and uninvolved
lymph nodes, there is a slightly lower
T-cell proportion in the "normal" lym-
phoid control group. The proportional
distribution of cells expressing "helper"
and "suppressor" antigens is, however,
very similar. The proportions of B cells
defined by our methods do not vary
significantly between tissues, and account
for 20% of leucocytes. A normal
polyclonal profile is observed, findings
similar to those of Bobrove et al. (1975).
The significance of the findings in the
spleens of patients must remain specula-
tive until appropriate numbers of normal
controls for comparison are available.
Despite in vivo and in vitro demon-
stration of defective T-cell function in
HD, this does not appear to result from
deficiencies in the proportions of the T or
B cells or T-subset ratios in diseased
tissues. This suggests that some intrinsic
functional immune deficiency is a signifi-
cant feature in the pathogenesis of HD.
Further work will attempt to clarify the
micro-anatomical relationships of T and
B subsets within the HD lesion, and to
study some of the functional attributes
of T cells from diseased tissues, in the
hope of elucidating the nature of Hodg-
kin's disease.
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